Jurnal Internasional Sel hematopoietik haploidentik dan transplantasi ginjal untuk keganasan hematologis dan gagal ginjal stadium akhir

Download Disini
Jurnal Internasional Sel hematopoietik haploidentik dan transplantasi ginjal untuk keganasan hematologis dan gagal ginjal stadium akhir

Download Journal Here

At Massachusetts General Hospital, we pioneered simultaneous hematopoietic cells (HCT) / simultaneous kidney transplants from HLA-related donors for the treatment of haematological malignancies with end-stage renal failure. We have now extended this to HLA-haploidentical donors in pilot trials. Six recipients, 5 of which were conditioned with fludarabine, cyclophosphamide, and total-body irradiation, underwent a combined HCT / kidney transplant from a haploidentical donor; prophylaxis of graft-versus-host disease (GVHD) includes post-HCT cyclophosphamide, tacrolimus, and mycophenolate mofetil. One patient died due to complications from fludarabine neurological toxicity. No neurological toxicity was observed in subsequent patients who received a lower dose of fludarabine and more intense postfludarabine dialysis. There were no cases of acute GVHD grade 2 to 4 and 1 case of chronic GVHD moderate at 12 months. One patient experienced multiple myeloma recurrence at 30 months after HCT and died 4 years after transplantation. Overall, 4 of 6 patients remained alive, without disease recurrence and with long-term free kidney rejection survival. This trial is listed at www.clinicaltrials.gov as # NCT01758042.

Download Journal Here

Tags:

Download Disini